Literature DB >> 4765720

Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity.

R N MacSween, I Galbraith, M A Thomas, G Watkinson, G B Ludlam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4765720      PMCID： PMC1553872     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

1.  Two cases of hepatitis due to Toxoplasma gondii.

Authors:  T L Vischer; C Bernheim; E Engelbrecht
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

2.  Evidence for transformation of human B lymphocytes by PHA.

Authors:  B Phillips; I M Roitt
Journal:  Nat New Biol       Date:  1973-02-21

3.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

4.  Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy.

Authors:  D T Purtilo; H M Hallgren; E J Yunis
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

5.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

6.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

7.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

8.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

9.  Toxoplasmosis.

Authors:  D G Fleck
Journal:  Public Health       Date:  1969-03       Impact factor: 2.427

10.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.

Authors:  G Janossy; M F Greaves
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330
View more
  9 in total

1.  Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis.

Authors:  H C Thomas; R Holden; J V Jones; D B Peacock
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

2.  A clinical trial of levamisole in primary biliary cirrhosis.

Authors:  S Hishon; G Tobin; P J Ciclitira
Journal:  Postgrad Med J       Date:  1982-11       Impact factor: 2.401

Review 3.  Serology of primary biliary cirrhosis.

Authors:  P A Berg; H Baum
Journal:  Springer Semin Immunopathol       Date:  1980-12

4.  In-vitro reactions of lymphocytes in rheumatoid arthritis and other rheumatic diseases.

Authors:  K Froebel; R D Sturrock; P Reynolds; A Grennan; A Roxburgh; R N MacSween
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

5.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

6.  In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors:  J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

7.  Lymphocytotoxic antibodies in primary biliary cirrhosis.

Authors:  A Parés; J Martorell; J Caballería; J Vives; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

Review 8.  Some immunological aspects of liver function.

Authors:  D R Triger
Journal:  Yale J Biol Med       Date:  1975-03

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.